Constellation Brands
About: Constellation Brands is the largest provider of alcoholic beverages across the beer, wine, and spirits categories in the U.S., generating 80% of revenue from Mexican beer imports under top-selling brands such as Modelo and Corona. The rest of the business includes some remaining wine and spirits brands, categories where the company continue to prune assets in recent years. With its exclusive rights tied to the Mexican beer brands effective only in the U.S., the firm has small revenue exposure to international markets. Constellation owns a 36% stake in no-moat Canopy Growth, a medicinal and recreational cannabis producer in Canada, and has a 50/50 joint venture with glass manufacturer Owens-Illinois in Mexico.
Employees: 10,600
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
4% less repeat investments, than reductions
Existing positions increased: 481 | Existing positions reduced: 503
4% less funds holding
Funds holding: 1,317 [Q2] → 1,269 (-48) [Q3]
5.8% less ownership
Funds ownership: 84.4% [Q2] → 78.6% (-5.8%) [Q3]
7% less capital invested
Capital invested by funds: $39.6B [Q2] → $36.8B (-$2.81B) [Q3]
35% less first-time investments, than exits
New positions opened: 91 | Existing positions closed: 139
43% less call options, than puts
Call options by funds: $380M | Put options by funds: $663M
50% less funds holding in top 10
Funds holding in top 10: 12 [Q2] → 6 (-6) [Q3]
Research analyst outlook
16 Wall Street Analysts provided 1 year price targets over the past 3 months
16 analyst ratings
BMO Capital Andrew Strelzik 63% 1-year accuracy 20 / 32 met price target | 28%upside $305 | Outperform Maintained | 15 Oct 2024 |
TD Cowen Robert Moskow 42% 1-year accuracy 10 / 24 met price target | 14%upside $270 | Hold Downgraded | 8 Oct 2024 |
Barclays Lauren Lieberman 41% 1-year accuracy 36 / 87 met price target | 26%upside $300 | Overweight Maintained | 7 Oct 2024 |
B of A Securities Bryan Spillane 56% 1-year accuracy 10 / 18 met price target | 7%upside $255 | Neutral Downgraded | 7 Oct 2024 |
JP Morgan Andrea Teixeira 46% 1-year accuracy 26 / 56 met price target | 23%upside $293 | Overweight Maintained | 4 Oct 2024 |
Financial journalist opinion
Based on 4 articles about STZ published over the past 30 days